Zimmer Biomet unveils suite of robotic and digital technologies

MedTech News: Zimmer Biomet introduces its Connected Intelligence Suite of currently available and soon to be launched digital and robotic technologies in orthopaedics.  

Zimmer’s ZBEdge suite integrates its ROSA Robotics Platform for total knee replacement procedures with separate surgical planning, joint alignment and navigation tools as well as the company’s mymobility app, which uses the sensors in Apple Watch and iPhone to track a patient’s progress through pre- and post-operative exercises.

“ZBEdge Connected Intelligence Suite is grounded in Zimmer Biomet’s innovative robotics and digital health tools and heritage in clinically-proven implant technologies. The ZBEdge Connected Intelligence Suite enables healthcare professionals to connect the dots between procedural and patient data at every stage of the surgical journey. ZBEdge technologies are designed with the dual goals of reducing variability of care and enhancing outcomes,” said Ivan Tornos, Chief Operating Officer at Zimmer Biomet.  

“As we continue to pioneer breakthrough technologies and grow the ZBEdge Connected Intelligence Suite, we will be able to deliver greater value to healthcare professionals and advance our mission to alleviate pain and improve the quality of life for people around the world.”

The ZBEdge Connected Intelligence Suite offers hospitals and ambulatory surgery centres access to a robust set of pre-, intra- and post-operative technologies designed to create an integrated product experience that draws upon data from Zimmer Biomet devices, robotics and digital technologies used throughout each patient’s episode of care.  

This data is then aggregated, analysed and translated into actionable clinical insights that can inform and enhance a surgeon’s care decisions through the OrthoIntel Orthopaedic Intelligence Platform.  Each of these tools has been purpose-built by Zimmer Biomet to unlock this critical information and deliver it through a user experience that integrates seamlessly into the workflow of today’s surgeons and care teams.

“By connecting Zimmer Biomet’s innovative technologies under the unified ZBEdge portfolio, we are solidifying our commitment to delivering solutions that optimize the patient experience by empowering healthcare professionals with actionable data-derived clinical insights,” Mr Tornos added.

“In addition, the ZBEdge suite includes patient-facing digital technologies like mymobility with Apple Watch that give patients the opportunity to access their own healthcare data and take a more engaged and active role in their care and recovery,” he noted.

Zimmer Biomet Asia Pacific told Health Industry Hub that due to the differing regulatory requirements and timelines, the entire ZBEdge suite may not currently be available in all the countries within the region.

The ROSA Robotics Platform has been launched in most of the Asia Pacific countries including Australia, Japan, India, Singapore, China, Malaysia and Thailand. However, at this time, the mymobility system and OrthoIntel Orthopaedic Intelligence Platform have only been released in Australia and New Zealand.